Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Cannabix Technologies (BLO), a developer of marijuana breathalyzers, has appointed Dr. Mo Paknahad as its Vice President of Technology
  • Dr. Paknahad is a specialist in microfluidics, machine olfaction, sensors, organ-on-chip and lab-on-chip technologies
  • In conjunction with the appointment, Cannabix has also issued Dr. Paknahad 200,000 stock options at C$0.80, exercisable for two years
  • Shares in the company are currently up 2.94 per cent to C$0.70, with a market cap of C$73.59 million

Cannabix Technologies Inc. (BLO), a developer of marijuana breathalyzers, has appointed Dr. Moe Paknahad as Vice President of Technology.

Having spent the last decade researching biomedical and environmental detection devices, Dr. Paknahad will be responsible for leading the development of Cannabix’s THC breathalyzers.

Dr. Paknahad received a PhD in Electrical Engineering from the University of British Columbia and completed his post-doctorate at the University of Toronto.

With recent experience at CellScale Biomaterials and VitroFlo in Ontario, Dr. Paknahad is a specialist in microfluidics, machine olfaction, sensors, organ-on-chip and lab-on-chip technologies.

In addition, Dr. Paknahad served a key role at the University of British Columbia in the development of microfluidic gas analysis technology which is currently used in a wide range of applications, from human breath analysis to gas leak detection in natural gas infrastructures.

“Dr. Paknahad has deep knowledge of sensor technologies, pilot prototype production as well as commercialization and will be a great addition to our technical team for both microfluidic technologies and FAIMS,” said Dr. Raj Attariwala, Chief Scientific Officer of Cannabix.

In combination with the new appointment, Cannabix Technologies has also issued Dr. Paknahad 200,000 stock options at C$0.80, exercisable for a period of two years.

Earlier this year, Cannabix announced sensitivity improvements to its FAIMS (field asymmetric waveform ion mobility spectrometry) THC detection device, which was the subject of extensive refinement over the preceding months.

Shares in the company are currently up 2.94 per cent to C$0.70, with a market cap of C$73.59 million.

More From The Market Herald

" West Island Brands (CSE:WIB) announces new appointments

West Island Brands (WIB) has strengthened its team with three new appointments.

" Cronos (TSX:CRON) unveils new CBC product

Cronos Group (CRON) announced the launch of a CBC-focused product, the Spinach FEELZ THC+CBC Day Trip Mango Lime gummies.

" Tilray Brands’ (TSX:TLRY) Good Supply Cannabis brand launches ‘Peppermint Phatty’

Tilray (TLRY) announced the newest addition to its Good Supply vape lineup with the launch of Peppermint Phatty 510 vape.

" Delta 9 (TSX:DN) opens 39th cannabis retail store

Delta 9 (DN) announced the grand opening of its 39th Delta 9 Cannabis retail store, the 17th in the province of Manitoba.